- Home
- ENTO vs NIVF Comparison
ENTO vs NIVF Comparison
Compare ENTO & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTO
- NIVF
- Stock Information
- Founded
- ENTO 2014
- NIVF 2011
- Country
- ENTO United States
- NIVF Hong Kong
- Employees
- ENTO N/A
- NIVF N/A
- Industry
- ENTO Biotechnology: Pharmaceutical Preparations
- NIVF
- Sector
- ENTO Health Care
- NIVF
- Exchange
- ENTO Nasdaq
- NIVF NYSE
- Market Cap
- ENTO 1.7M
- NIVF 2.1M
- IPO Year
- ENTO 2016
- NIVF N/A
- Fundamental
- Price
- ENTO $0.42
- NIVF $3.38
- Analyst Decision
- ENTO
- NIVF
- Analyst Count
- ENTO 0
- NIVF 0
- Target Price
- ENTO N/A
- NIVF N/A
- AVG Volume (30 Days)
- ENTO 91.6K
- NIVF 351.5K
- Earning Date
- ENTO 05-20-2025
- NIVF 01-01-0001
- Dividend Yield
- ENTO N/A
- NIVF N/A
- EPS Growth
- ENTO N/A
- NIVF N/A
- EPS
- ENTO N/A
- NIVF N/A
- Revenue
- ENTO N/A
- NIVF $5,433,375.00
- Revenue This Year
- ENTO N/A
- NIVF N/A
- Revenue Next Year
- ENTO N/A
- NIVF N/A
- P/E Ratio
- ENTO N/A
- NIVF N/A
- Revenue Growth
- ENTO N/A
- NIVF 5.79
- 52 Week Low
- ENTO $0.19
- NIVF $1.09
- 52 Week High
- ENTO $3.16
- NIVF $32.80
- Technical
- Relative Strength Index (RSI)
- ENTO 54.25
- NIVF 40.15
- Support Level
- ENTO $0.32
- NIVF $2.82
- Resistance Level
- ENTO $0.37
- NIVF $4.96
- Average True Range (ATR)
- ENTO 0.03
- NIVF 0.80
- MACD
- ENTO 0.01
- NIVF 0.30
- Stochastic Oscillator
- ENTO 89.72
- NIVF 33.61
About ENTO Entero Therapeutics Inc. Common Stock
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.